These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 18063881

  • 21. Effects of eye drops containing a mixture of 3% diquafosol sodium and tocopherol acetate (vitamin E) on the ocular surface of murine dry eye.
    Li L, Jin R, Li Y, Yoon HS, Yoon HJ, Yoon KC.
    Cutan Ocul Toxicol; 2021 Dec; 40(4):350-358. PubMed ID: 34496685
    [Abstract] [Full Text] [Related]

  • 22. The correlation of routine tear function tests and conjunctival impression cytology in dry eye syndrome.
    Kumar P, Bhargava R, Kumar M, Ranjan S, Kumar M, Verma P.
    Korean J Ophthalmol; 2014 Apr; 28(2):122-9. PubMed ID: 24688254
    [Abstract] [Full Text] [Related]

  • 23. Comparison of Topical Application of TSG-6, Cyclosporine, and Prednisolone for Treating Dry Eye.
    Kim YJ, Ryu JS, Park SY, Lee HJ, Ko JH, Kim MK, Wee WR, Oh JY.
    Cornea; 2016 Apr; 35(4):536-42. PubMed ID: 26807900
    [Abstract] [Full Text] [Related]

  • 24. Evaluation of Clinical Efficacy and Safety of a Novel Cyclosporin A Nanoemulsion in the Treatment of Dry Eye Syndrome.
    Kim HS, Kim TI, Kim JH, Yoon KC, Hyon JY, Shin KU, Choi CY.
    J Ocul Pharmacol Ther; 2017 Sep; 33(7):530-538. PubMed ID: 28759302
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of oxidative stress levels in the conjunctival epithelium of patients with or without dry eye, and dry eye patients treated with preservative-free hyaluronic acid 0.15 % and vitamin B12 eye drops.
    Macri A, Scanarotti C, Bassi AM, Giuffrida S, Sangalli G, Traverso CE, Iester M.
    Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):425-30. PubMed ID: 25398660
    [Abstract] [Full Text] [Related]

  • 26. Impact of Topical 0.05% Cyclosporine A Eye Drops on Post-Femtosecond-Assisted Laser In Situ Keratomileusis Ocular Surface Recovery: A Randomized Clinical Trial.
    Zhao L, Duan H, Ma B, Yang T, Zhou Y, Liu Y, Chen J, Chen Y, Qi H.
    Eye Contact Lens; 2024 Aug 01; 50(8):348-356. PubMed ID: 38865592
    [Abstract] [Full Text] [Related]

  • 27. Combining Sodium Hyaluronate and Polyvinylpyrrolidone Therapies for the Rabbit Cornea: A New Approach to Relief of the Human Dry Eye Syndrome.
    Ehrenberg M, Zolotariov E, Loeb E, Poliansky V, Levy A.
    Curr Eye Res; 2015 Sep 01; 40(9):913-22. PubMed ID: 25329624
    [Abstract] [Full Text] [Related]

  • 28. Development of a rabbit model of tear film instability and evaluation of viscosity of artificial tear preparations.
    Nakamura S, Okada S, Umeda Y, Saito F.
    Cornea; 2004 May 01; 23(4):390-7. PubMed ID: 15097136
    [Abstract] [Full Text] [Related]

  • 29. A comparison of vitamin a and cyclosporine a 0.05% eye drops for treatment of dry eye syndrome.
    Kim EC, Choi JS, Joo CK.
    Am J Ophthalmol; 2009 Feb 01; 147(2):206-213.e3. PubMed ID: 18848318
    [Abstract] [Full Text] [Related]

  • 30. RGN-259 (thymosin β4) improves clinically important dry eye efficacies in comparison with prescription drugs in a dry eye model.
    Kim CE, Kleinman HK, Sosne G, Ousler GW, Kim K, Kang S, Yang J.
    Sci Rep; 2018 Jul 12; 8(1):10500. PubMed ID: 30002412
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy.
    Toker E, Asfuroğlu E.
    Cornea; 2010 Feb 12; 29(2):133-40. PubMed ID: 19966564
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The effect of intense pulsed light combined with topical 0.05% Cyclosporin A eyedrops in the treatment of Sjögren's syndrome related dry eye.
    Huo Y, Huang X, Lin L, Yang S, Qin Z, Yirui Z, Mou Y, Jin X.
    Expert Rev Clin Immunol; 2024 Oct 12; 20(10):1261-1267. PubMed ID: 38785065
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of topical nerve growth factor treatment in dogs affected by dry eye.
    Coassin M, Lambiase A, Costa N, De Gregorio A, Sgrulletta R, Sacchetti M, Aloe L, Bonini S.
    Graefes Arch Clin Exp Ophthalmol; 2005 Feb 12; 243(2):151-5. PubMed ID: 15650854
    [Abstract] [Full Text] [Related]

  • 36. Effect of diquafosol tetrasodium 3% on the conjunctival surface and clinical findings after cataract surgery in patients with dry eye.
    Cui L, Li Y, Lee HS, Yang JM, Choi W, Yoon KC.
    Int Ophthalmol; 2018 Oct 12; 38(5):2021-2030. PubMed ID: 28822028
    [Abstract] [Full Text] [Related]

  • 37. Cationized hyaluronic acid coated spanlastics for cyclosporine A ocular delivery: Prolonged ocular retention, enhanced corneal permeation and improved tear production.
    Liu Y, Wang Y, Yang J, Zhang H, Gan L.
    Int J Pharm; 2019 Jun 30; 565():133-142. PubMed ID: 31075435
    [Abstract] [Full Text] [Related]

  • 38. The effect of additional topical cyclosporine or vitamin A on the ocular surface during antiglaucoma medication administration.
    Cho HK, Park MH, Moon JI.
    Ophthalmic Res; 2012 Jun 30; 48(3):139-45. PubMed ID: 22572974
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Long-term topical cyclosporine treatment improves tear production and reduces keratoconjunctivitis in rabbits with induced autoimmune dacryoadenitis.
    Thomas PB, Samant DM, Zhu Z, Selvam S, Stevenson D, Wang Y, Song SW, Mircheff AK, Schechter JE, Yiu SC, Trousdale MD.
    J Ocul Pharmacol Ther; 2009 Jun 30; 25(3):285-92. PubMed ID: 19456259
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.